Greek NIS Spiolto ELLACTO
NCT03419962
·
clinicaltrials.gov ↗
COMPLETED
Status
1360
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
MaxSpiolto® Respimat® 160 Characters...
Sponsor
Boehringer Ingelheim